Doctors

Chief Physician, Professor, and Doctoral Supervisor. Dr. Jianchun Yu specializes in gastrointestinal surgery and nutrition metabolism. Her clinical and basic research focuses on parenteral and enteral nutrition, including the evaluation of gastric cancer, neoadjuvant chemotherapy and nutritional support, standardized radical gastrectomy for gastric cancer, parenteral and enteral nutrition support and surgical treatment for intestinal fistula, and radical surgery for thyroid cancer. She is highly experienced in minimally invasive laparoscopic surgery, such as gastroscopically controlled laparoscopic segmental cardia or pylorus-reservation gastrectomy for the treatment of gastric stromal tumors and early gastric cancer, laparoscopic gastric banding, laparoscopic sleeve gastrectomy, laparoscopic Nissen fundoplication, abdominal hernia laparoscopic repair, percutaneous endoscopic gastrostomy (PEG) / percutaneous endoscopic gastro-jejunal (PEG-J), and jejunal interposition. Born in 1962, Dr. Yu holds an MD and serves as a Chief Physician, Professor, and Doctoral Supervisor at the Chinese Academy of Medical Sciences and Peking Union Medical College. She has been dedicated to perioperative parenteral and enteral nutrition, gastrointestinal tumor chemotherapy and immunonutrition, tumor and nutritional immunity, parenteral and enteral nutrition and gastrointestinal motility research, nutritional screening and standardization for elderly patients, and the mechanism of metabolic changes related to weight loss and diabetes surgical treatment. She has led multiple national multi-center clinical studies and has undertaken over 10 major national and provincial scientific research projects, training 35 graduate students. She has published over 100 articles in domestic and international journals and served as editor-in-chief or co-editor for numerous professional books.

Associate Professor, Associate Chief Physician, and Master's Supervisor. Dr. Jianfeng Zhou (MD) is an Associate Professor of Medical Oncology at Peking Union Medical College Hospital. She graduated from Peking Union Medical College in 1999 and has worked at Peking Union Medical College Hospital since then. She has been engaged in medical oncology since 2003 and studied at the UCSF Comprehensive Cancer Center in the United States in 2012. She specializes in oncology, especially devoted to the clinical treatment and research of digestive system tumors. She is a core member of the multidisciplinary treatment (MDT) team for gastrointestinal tumors at Peking Union Medical College Hospital. She specializes in the comprehensive and individualized treatment of colorectal cancer, and has rich experience in the comprehensive treatment of other digestive system tumors, lung cancer, breast cancer, and head and neck tumors. She has published over 20 academic papers in domestic and international journals. She serves as the Principal Investigator (PI) for two multi-center Phase III clinical trials of new drugs for advanced colorectal cancer, and is a Sub-Investigator (Sub-I) for multiple domestic and international clinical trials. She has received funding from the Chinese Academy of Medical Sciences Youth Fund and the CSCO Special Fund to conduct basic and clinical research on gastrointestinal tumors.

Professor Jianxiong Shen is a Chief Physician, Professor, and Doctoral Supervisor in the Department of Orthopedics. He specializes in the surgery and post-surgical functional recovery of spinal scoliosis and degenerative diseases. He has profound expertise in the diagnosis and treatment of various spinal conditions, particularly spinal scoliosis. He is highly experienced in scoliosis correction and the establishment of post-operative spinal function. Professor Shen is among the pioneers in China to utilize TSRH, CDH, ISOLA, and Galveston techniques for treating scoliosis. He performs over 100 scoliosis correction surgeries annually, successfully treating complex and high-risk spinal deformities, including cases leading to paraplegia, and frequently conducts revision surgeries. He also extensively performs surgeries for degenerative spinal conditions. Professor Shen serves as the Vice Chairman of the Spinal Deformity Group of the Spinal Cord Injury Professional Committee of the Chinese Association of Rehabilitation Medicine, and Vice Chairman of the Spine Branch of the Orthopedics Professional Committee of the China Medicine Education Association. He is a member of the Scoliosis Research Society (SRS) and serves on the editorial boards of several prestigious journals, including Spine.

Attending Physician. Dr. Jiawei Liu holds an MD in Dermatology and Venereology from Peking Union Medical College. She is dedicated to the diagnosis and treatment of dermatological and sexually transmitted diseases, with extensive clinical experience in common skin conditions, cosmetic dermatology, immune-related skin diseases, and genetic skin disorders. Her clinical expertise includes the diagnosis and treatment of atopic dermatitis, psoriasis, nevi, vitiligo, and hyper-pigmented dermatosis. She is highly skilled in managing acne, rosacea, and sensitive skin, as well as performing skin rejuvenation treatments such as laser therapy and Botox injections. Additionally, she specializes in female vulvar skin disorders, genodermatosis (including gene diagnosis and prognosis counseling), immune-related skin diseases (such as lupus erythematosus, scleroderma, and Still's disease), and infectious skin diseases (such as cutaneous tuberculosis and non-tuberculous mycobacteria).

Chief Physician, Professor, and Doctoral Supervisor. Dr. Gao has been engaged in clinical neurology for over 30 years and possesses rich clinical experience. She specializes in leukoencephalopathy, cognitive impairment, dementia, non-tumor cranial neuropathology, and cerebrovascular disease. She serves as the Deputy Leader of the Dementia and Cognitive Impairment Group of the Neurology Branch of the Chinese Medical Association, a member of the Neuropathology Group, a Standing Committee Member of the Neurology Branch of the Beijing Medical Association, Leader of the Neuropathology Group, and Deputy Leader of the Dementia and Cognitive Impairment Group. She has also been invited to participate in several other academic committees on dementia and degenerative diseases. She is an editorial board member for the Chinese Journal of Neurology, the Chinese edition of the BMJ, and the Chinese Journal of Multiple Organ Diseases in the Elderly. Her specialized clinic for dementia and leukoencephalopathy has served patients for many years. She has accumulated extensive experience in the evaluation, diagnosis, differential diagnosis, and treatment of cognitive impairment and dementia, white matter abnormalities, leukoencephalopathy, and leukodystrophy. Her work in non-tumor brain pathology has helped doctors better understand the nature of diseases. She not only has international professional training and experience in epilepsy pathology and neurodegenerative diseases but has also collaborated with peers and other departments to diagnose rare intracranial granulomas and various inflammatory and infectious encephalopathies, allowing patients to receive timely and effective treatment. She actively promotes autopsy pathology research on dementia-related diseases in China.

Chief Physician, Professor, and Doctoral Supervisor. Specializes in clinical and basic research of allergic disorders, especially dust mite allergy, pollen allergy, anaphylaxis, and food allergy. He serves as a member of the Environment and Health Standards Committee of the National Health Commission, Director of the Chinese Research Hospital Association, Academic Leader of the State Key Laboratory of Complex Severe and Rare Diseases, and Academic Leader of the National Clinical Research Center for Immunological Diseases. He is also the Chairman of the Allergy Medicine Professional Committee of the Chinese Research Hospital Association, a consulting expert for the Center for Drug Evaluation of the National Medical Products Administration, a judge for the National Natural Science Foundation of China, and the Academic Leader of the Beijing Key Laboratory of Precision Diagnosis and Treatment of Allergic Diseases. Furthermore, he is the Deputy Leader of the Basic Research and Translational Medicine Group for Allergic Diseases of the Allergy Branch of the Chinese Medical Association, and an Editorial Board Member of the Chinese Journal of Allergy and Clinical Immunology.

Chief Physician, Professor, and Doctoral Supervisor. Specializes in the diagnosis and treatment of common and rare pediatric diseases, including hematological and neoplastic diseases, especially fever of unknown origin, anemia, purpura, hemophilia, germ cell tumors, infectious diseases, and some immunological diseases. Dr. Juan Xiao received her Ph.D. from Peking Union Medical College in 2000. She was a visiting scholar at Children's Hospital Los Angeles, University of Southern California in 2010, and at the Cumming School of Medicine, University of Calgary, Canada in 2018. Her research focuses on pediatric hematological and neoplastic diseases. She has undertaken multiple national scientific research projects, presided over various domestic and international multi-center clinical studies, and published over 100 academic papers.

Chief Physician, Professor, and Doctoral Supervisor. Specializes in the diagnosis and treatment of difficult and rare diseases of the respiratory system. Has accumulated rich clinical experience particularly in eosinophilic lung diseases, pulmonary vasculitis, pulmonary embolism, severe refractory asthma, lung involvement of connective tissue diseases, lung infections, and interstitial lung diseases. Served successively as Resident, Chief Resident, Attending Physician, Associate Chief Physician, and Chief Physician at Peking Union Medical College Hospital. Completed a 1-year visiting scholarship at the Mayo Clinic.

Deputy Director of Neurosurgery, Chief Physician, Doctoral Supervisor, and Professor at Peking Union Medical College Hospital. Specializes in the diagnosis and treatment of pituitary adenomas, intracranial tumors, traumatic brain injury, cerebrovascular diseases, and hydrocephalus. He is highly skilled in the diagnosis and management of neurocritical diseases, as well as the comprehensive treatment of central nervous system infections and hydrocephalus. He graduated with an MD from Peking Union Medical College Hospital. He has pursued professional studies and academic exchanges in neurosurgery at several large hospitals in China. He was a visiting scholar at Brigham and Women's Hospital (BWH) affiliated with Harvard Medical School and the Cleveland Clinic (CCF). Relying on the multidisciplinary collaborative team advantages of Peking Union Medical College Hospital, he actively promotes the standardized management of neurocritical patients in China. He spearheaded the establishment of the Chinese Neurocritical Care Management Collaborative Group and led related collaborative units to co-author 11 Chinese consensus statements and guidelines. He is the director of national continuing medical education projects. Currently, he serves as the Head of the Chinese Neurocritical Care Management Collaborative Group; Member and Secretary of the Neurotrauma Group of the Neurosurgery Branch of the Chinese Medical Association; Member of the Neurotrauma Professional Group of the Trauma Branch of the Chinese Medical Association; Vice Chairman of the Severe Cerebrovascular Disease Branch of the Chinese Stroke Association; Member of the 7th Youth Committee of the Neurosurgery Branch of the Chinese Medical Association; Member and Deputy Secretary-General of the Hemorrhagic Stroke Surgery Professional Committee of the Stroke Prevention and Treatment Expert Committee of the National Health Commission; Vice Chairman of the Intracerebral Hemorrhage Surgery Diagnosis and Treatment Capacity Improvement Project of the National Health Commission; Member of the Neurocritical Care Expert Committee of the Neurosurgery Branch of the Chinese Medical Doctor Association; Member of the Neuro-nutritional Support Group of the Parenteral and Enteral Nutrition Branch of the Chinese Medical Association. He is also a national health emergency response guiding expert, a reviewer for the National Natural Science Foundation of China, a corresponding editorial board member and peer reviewer for the Chinese and English editions of the 'National Medical Journal of China', an editorial board member for the 'Journal of Clinical Neurosurgery' and 'Chinese Journal of Neurotrauma', and a peer reviewer for the 'Acta Academiae Medicinae Sinicae' and 'Basic & Clinical Medicine'. His research focuses on stem cell therapy for nerve injury, the mechanisms of nerve injury regeneration and repair, and the pathogenesis of hydrocephalus. He currently leads multiple research projects funded by the General Program of the National Natural Science Foundation of China, the Ministry of Education, the Beijing Municipal Science and Technology Commission, and the Chinese Academy of Medical Sciences. He has participated in major technological research and development plans of the Ministry of Science and Technology, three national '863 Program' studies, and multiple studies funded by the National Natural Science Foundation and the Capital Health Research and Development of Special.

Assistant to the Director, Associate Chief Physician, Associate Professor. Dr. Fan is the Assistant to the Director of the Department of Respiratory and Critical Care Medicine and holds an MD. He graduated from the 8-year clinical medicine program at Peking Union Medical College in 2011. In the same year, he began and completed his residency training in the Department of Internal Medicine at Peking Union Medical College Hospital, serving as the Chief Resident of Internal Medicine from 2015 to 2016. He possesses solid foundational skills in internal medicine and is highly proficient in the diagnosis and treatment of common respiratory diseases.

Chief Physician, Professor, and Doctoral Supervisor. Specializes in effective therapy and rehabilitation for chronic obstructive pulmonary disease (COPD) and asthma; diagnosis and treatment of difficult and rare respiratory diseases, including lymphangioleiomyomatosis (LAM), pulmonary alveolar proteinosis (PAP), cystic fibrosis (CF), tuberous sclerosis complex (TSC); diagnosis and treatment of pulmonary arterial hypertension; and chylothorax. Dr. Xu has 30 years of clinical experience. He graduated from Shanghai Medical University (now Fudan University) Medical School in 1988 and has been working at Peking Union Medical College Hospital since graduation. He obtained his Master's degree in Internal Medicine from the University of Melbourne, Australia (1995-1997), and his MD from Peking Union Medical College in 2002. From 2002 to 2005, he worked at the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) in the USA. He has rich clinical experience in common and rare respiratory diseases, with deep research in the long-term management and rehabilitation of COPD and asthma, as well as rare diseases like LAM and PAP.

Chief Physician and Professor. Professor Ke Tan graduated from China Medical University in 1984 and has been working in the Department of Ophthalmology at Peking Union Medical College Hospital. He is a renowned expert engaged in clinical, teaching, and research work in ophthalmology, with over 30 years of clinical experience. He specializes in the medical and surgical treatment of fundus diseases and ocular trauma, including diabetic retinopathy, retinal vascular diseases, and macular diseases. He has achieved significant efficacy using intraocular injections and laser therapy, and has accumulated extensive experience in performing vitrectomy for complex diabetic retinopathy, ocular fundus trauma, and macular diseases. Professor Tan has attended numerous domestic and international conferences, published nearly 20 papers, and served as editor-in-chief, deputy editor-in-chief, and co-author of multiple ophthalmology books.